GENINUS Inc. Logo

GENINUS Inc.

AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.

389030 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 송파구 정의로 70 4층, 5층(문정동, 케이디유타워), 송파구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Geninus Inc. is a biotechnology company specializing in genomic analysis for precision medicine. The company develops and provides solutions based on single-cell analysis, spatial multi-omics, and AI-driven platforms to deliver genetic insights for personalized treatment and disease prevention. Its core offerings include IntelliMed™, a clinical genomics service; MEDINSIGHT™, an AI-powered digital pathology solution for mapping transcriptomes; and SPACEINSIGHT™, a cloud-based platform for spatial multi-omics data analysis. Geninus supports pharmaceutical and clinical partners through services like biomarker and target discovery, patient stratification, Next-Generation Sequencing (NGS), and cancer genome companion diagnostics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-05-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 73.6 KB
2025-05-22 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제1회차 CB)
Korean 5.6 KB
2025-05-19 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 97.4 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.9 KB
2025-03-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.0 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.4 KB
2025-03-24 00:00
Related Party Transaction
[기재정정]타인에대한채무보증결정
Korean 23.5 KB
2025-03-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 26.2 KB
2025-03-17 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 436.9 KB
2025-03-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-03-10 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-03-06 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 142.9 KB

Automate Your Workflow. Get a real-time feed of all GENINUS Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GENINUS Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.